Project Grant HT94252410211
Award Date
7/1/24
Completion Date
6/30/28
Dollars Obligated
$3.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60637, USA
Similar Awards
The University of Chicago will receive $2,624,000 through a Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the role of amino acid metabolism in pulmonary fibrosis. Through this award, the University of Chicago aims to advance understanding of medical solutions for pulmonary disorders and translate findings into improved patient...
The University of Chicago was awarded a $1,306,778 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research focused on "Immunologic Drivers of Lineage Bias in TP53-Mutant Acute Leukemia". The research aims to transform healthcare for military service members and the broader public through innovative, impactful investigations across medical disciplines. The 4-year...
The University of Chicago will receive $1,229,184 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The funding will support research into microRNA-mediated regulation of prostate cancer biology. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions for battlefield medicine. The University of...
This federal Project Grant award of $820,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) was provided to the University of Chicago to conduct research on "Determining and Exploiting Metabolic Vulnerabilities of Cancer-Associated Fibroblast Heterogeneity." The research project aims to explore metabolic differences within cancer-associated fibroblasts and leverage those findings to develop new therapeutic approaches. The...
The University of Chicago was awarded a $2,624,000.00 Project Grant from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to fund the research project "TARGETING TISSUE-RESIDENT ALVEOLAR MACROPHAGE METABOLISM IN ACUTE LUNG INJURY". This four-year grant, running from April 1, 2024 to March 31, 2028, supports cutting-edge biomedical research aimed at improving health outcomes for military service members, veterans, and their families. The research...
The University of Chicago was awarded a $1,612,104 Project Grant under the Department of the Army's Military Medical Research and Development (CFDA 12.420) program. The grant, effective from February 1, 2025, to January 31, 2028, will support the development of "Senescent Tumor Cell-Loaded Dendritic Cell Vaccines for Breast Cancer." This research aims to transform healthcare for military service members and the broader public by advancing disease prevention, diagnosis, treatment, and...
This federal Project Grant award of $869,193 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding research at the University of Chicago to identify the pathogenesis of monosomy 7 in bone marrow failure (BMF). The 3-year award, which began on July 1, 2025, supports advanced biomedical research to transform healthcare for military service members and the general public. The University of Chicago, a renowned private research institution, will...
This federal Project Grant award of $1,312,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the adaptation of an inhaled substance use intervention for adolescent and young adult cancer survivors. The award to the University of Chicago will be used to develop and evaluate this novel therapeutic approach over the 4-year performance period from August 2025 to July 2029. The University of Chicago, a renowned private research...
This Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) provides $1,580,000.00 to the University of California, San Diego (UCSD) to conduct research on "MULTIOMIC APPROACHES FOR NONINVASIVE PREDICTION OF INFLAMMATORY BOWEL DISEASE EXACERBATIONS." The 3-year project, beginning March 1, 2025, aims to advance scientific understanding and develop innovative methods for predicting flare-ups in inflammatory...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,602,572.00 in funding to the University of Illinois to support research on the role of the novel hexokinase HKDC1 in hepatocellular carcinoma. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Illinois, a major public research university in Chicago, will conduct innovative scientific studies to advance...